Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Express Scripts
Fuji
Julphar
Farmers Insurance
Covington
UBS
Citi
Healthtrust

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,251,426

« Back to Dashboard

Summary for Patent: 6,251,426
Title: Ibuprofen-containing softgels
Abstract:Liquid softgel fill formulations containing ibuprofen in free acid form, and softgel capsules comprised of a gelatin sheath enclosing such fill formulations, are prepared by dissolving more than 30% of ibuprofen in free acid form in polyethylene glycol and at least 10% by weight of a polyvinylpyrrolidone having an average molecular weight of from about 2,000 to about 54,000. The formulations may also include a surfactant to increase the bioavailability of the ibuprofen.
Inventor(s): Gullapalli; Rampurna Prasad (Greensboro, NC)
Assignee: Banner Pharmacaps, Inc. (High Point, NC)
Application Number:09/389,003
Patent Claim Types:
see list of patent claims
Formulation; Dosage form;

Drugs Protected by US Patent 6,251,426

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bionpharma Inc MIDOL LIQUID GELS ibuprofen CAPSULE;ORAL 021472-001 Oct 18, 2002 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,251,426

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan 2003508434 ➤ Subscribe
European Patent Office 1207872 ➤ Subscribe
Germany 60034044 ➤ Subscribe
Canada 2382292 ➤ Subscribe
Australia 780212 ➤ Subscribe
Australia 7094900 ➤ Subscribe
Austria 357229 ➤ Subscribe
Poland 362850 ➤ Subscribe
World Intellectual Property Organization (WIPO) 0115688 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Accenture
Argus Health
Daiichi Sankyo
AstraZeneca
Citi
Chubb
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot